Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Thermo Fisher Scientific Inc., the world leader in serving science, announced a 15-year strategic collaboration agreement to enable dedicated large-scale manufacturing in the US of Spikevax, Moderna
